The story
Founded by Kamel Khalili.1
Private company
Excision BioTherapeutics
American biotechnology company
Excision BioTherapeutics was a biopharmaceutical company based in San Francisco focused on developing gene therapies against HIV infection. The company had a single, CRISPR–Cas9 based therapy, EBT-101, that was under investigation.2 It was founded by Kamel Khalili.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrybiotechnology industry1
- HeadquartersSan Francisco1
- Websitewww.excision.bio
See how the biggest companies compare on our leaderboards
Excision BioTherapeutics was a biopharmaceutical company based in San Francisco focused on developing gene therapies against HIV infection. The company had a single, CRISPR–Cas9 based therapy, EBT-101, that was under investigation.2
Leadership
Who has led Excision BioTherapeutics, and when. Pick a name to see everywhere that person has worked.
- FounderKamel Khalili1
Links
- Websitewww.excision.bio1
- X (Twitter)x.com/ExcisionBio1
- LinkedInwww.linkedin.com/company/excisionbiotherapeutics1
- WikipediaExcision BioTherapeutics
- WikidataQ123252511
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2